Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Protein

Este producto es parte de KDR - kinase insert domain receptor
Product Graph
312€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx694174
tested applications
SDS-PAGE

Description

Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryProteins and Peptides
HostHEK293 cells
OriginHuman
Observed MWMolecular Weight: Calculated MW: 83.93 kDa Observed MW (SDS-PAGE): 90 kDa Sequence Fragment: Met1-Glu764 Tag: C-terminal His tag
ExpressionRecombinant
Purity>95% (SDS-PAGE)
Size 120 µg
Size 2100 µg
FormLyophilized Reconstitute in sterile H2O. Do not vortex.
Tested ApplicationsSDS-PAGE
BufferPrior to lyophilization: PBS, pH 7.4, containing 5% - 8% Trehalose, Mannitol and 0.01% Tween-80.
AvailabilityShipped within 5-15 working days.
StorageStore lyophilized between -20 °C and -80 °C.
Dry IceNo
UniProt IDP35968
AliasFLK1,CD309,VEGFR,VEGFR2,VEGFR-2,Protein-tyrosine kinase receptor flk-1,Fetal liver kinase 1,Vascular endothelial growth factor receptor 2
BackgroundProtein KDR
StatusRUO
NoteThis product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

KDR, also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a critical protein in the regulation of angiogenesis and vascular development. This receptor tyrosine kinase (RTK) is encoded by the KDR gene located on chromosome 4q12 in humans. KDR is a member of the VEGF receptor family, which plays an essential role in the processes of vasculogenesis and angiogenesis by mediating the cellular responses to the vascular endothelial growth factor (VEGF). The VEGF family consists of several ligands, with VEGF-A being the primary ligand for KDR. KDR is predominantly expressed in endothelial cells, where it regulates vascular permeability, endothelial cell proliferation, migration, and survival. Due to its pivotal role in vascular biology, KDR has been extensively studied in the context of cancer, where angiogenesis is a crucial process for tumor growth and metastasis. KDR's involvement in pathological angiogenesis makes it a significant target for anti-angiogenic therapies in cancer treatment. Moreover, it has implications in other diseases characterized by abnormal vascular growth, such as age-related macular degeneration and rheumatoid arthritis.

Related Products

EH0329

Human VEGFR2/KDR(Vascular endothelial growth factor receptor 2) ELISA Kit

Ver Producto
EM1445

Mouse VEGFR-2/KDR(Vascuoar Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto
ER1426

Rat VEGFR-2/KDR(Vascular Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto